The Moat Index
Compare moats, side by side.
Two to four companies, scored on the same five investor questions from their SEC filings — so the comparison is apples to apples. The method is fully public.
CHRS · Healthcare · Shallow moat
Doesn't clear the bar
The returnsOnCapital component abstained: Not enough years of ROIC data to score returns on capital. The other four 20% weights were renormalized over the scored 80%.
| Measure | CHRS | MLAB | NEPH | GEHC |
|---|---|---|---|---|
| Moat Score (0–100) | 50 (highest) | 50 (highest) | 50 (highest) | 50 (highest) |
| Methodology version | moat-index@2.0.0 | moat-index@2.0.0 | moat-index@2.0.0 | moat-index@2.0.0 |
| Business trend | 74 (highest) | 68 | 57 | 54 |
| Pricing power | 74 | 98 (highest) | 92 | 70 |
| Returns on capital | — | 0 | 4 | 63 (highest) |
| Balance-sheet safety | 28 | 42 | 73 (highest) | 41 |
| Capital discipline | 24 | 43 (highest) | 24 | 21 |
| Price vs. high estimate | No price data | 32% above high estimate | No price data | No price data |
| Market cap | $172.0M | $534.1M | $39.2M | — |
| Moat tier | Shallow moat | Shallow moat | Shallow moat | Shallow moat |
| Filings as of | FY2025 | FY2026 | FY2025 | FY2025 |